Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

SHANGHAI, March 29, 2024 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that th...

2024-03-29 20:00 1770

IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma

SHANGHAI and NANJING, China and SAN JOSE, Calif., March 29, 2024 /PRNewswire/ -- IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, today announced thatChina National Medical Products Administratio...

2024-03-29 17:20 1717

Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights

SUZHOU, China, March 29, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year endedDecember 31, 2023 and highlighted recent progress and upcoming milestones. Dr. Ting Xu, Chairman and CEO of Alphamab Oncology, commented, "In 2023, Alphamab Onc...

2024-03-29 10:42 8291

Jacobio Pharma Announces 2023 Annual Results

BEIJING, SHANGHAI and BOSTON, March 28, 2024 Jacobio/PRNewswire/ -- Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue wasRMB63.5 million, the R&D investment wasRMB372 million, the cash and cash equivalent at...

2024-03-29 08:50 4422

Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade

SEONGNAM, South Korea and ATLANTA, March 28, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330) , a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr.Jessica M...

2024-03-29 06:00 4111

FullCare Medical starts medical garment production at Tatu City, Kenya

USD-30-million facility employs 1,800 Kenyans in first phase TATU CITY, Kenya, March 28, 2024 /PRNewswire/ -- FullCare Medical has launched a new medical garment production facility in Tatu City, the 5,000-acre mixed-use Special Economic Zone (SEZ) inKenya.

2024-03-28 23:25 2952

FullCare Medical starts medical garment production at Tatu City, Kenya

Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future

Highlights of the Annual Results as of December 31, 2023: Revenue reached RMB2,155.6 million Gross profit amounted to RMB738.5 million Adjusted non-IFRS net loss improved to RMB208.8 million, representing a significant turnaround from a negative position compared to the corresponding period of las...

2024-03-28 22:46 8339

Broncus Medical (02216.HK) Announces Annual Results for 2023

The treatment products R&D continue to lead, and product sales are steadily advancing. HANGZHOU, China, March 28, 2024 /PRNewswire/ -- On March 28, 2024, Broncus Medical (02216.HK) (the "Company" or "we" ) announced annual results for FY 2023. In 2023, Broncus Medical earned product sales of US...

2024-03-28 22:32 4572

Harbour BioMed Reports Full Year 2023 Financial Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, March 28, 2024 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncol...

2024-03-28 22:10 3668

ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024

* Product News: ZEISS announces enhanced visualization capabilities with the new ZEISS ARTEVO 850 3D heads-up ophthalmic microscope. * Spatial Computing Innovation: ZEISS will demonstrate a digital application for experiencing 3D videos and more on the Apple Vision Pro. * Workflow Innovati...

2024-03-28 21:00 2214

Keosaa Launches Debut Electric Toothbrush on Amazon for Enhanced Oral Care

NEW YORK, March 28, 2024 /PRNewswire/ -- In an exciting announcement for dental hygiene enthusiasts and tech-savvy consumers alike, Keosaa has just launched its latest line of electric toothbrushes for a brighter, healthier smile. As we celebrate Oral Health Month, there is a better time to upgra...

2024-03-28 21:00 1659

Keosaa Launches Debut Electric Toothbrush on Amazon for Enhanced Oral Care

Primech Holdings Limited Provides Financial Updates and Corporate Highlights For the Six Months Ended September 30, 2023

SINGAPORE, March 28, 2024 /PRNewswire/ -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly inSingapore , provides a financial and corporate update coincident with t...

2024-03-28 20:30 3419

GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma

SHANGHAI, March 28, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced it has entered into a clinical trial collaboration and supply agreement with BeiGene Switzerland GmbH to start a c...

2024-03-28 19:00 2245

Tigermed Reports Full Year 2023 Results

HANGZHOU, China, March 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annua...

2024-03-28 18:31 3353

Sirnaomics Announces 2023 Annual Results

Focuses on the Consolidation for Leading Projects Accelerates Clinical Trials for Core Products STP705, STP707 and STP122G HONG KONG, Germantown, Md. and SUZHOU, China, March 28, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; st...

2024-03-28 17:09 4517

Coway Water Purifiers Certified for Microplastic Removal

* 26 direct-flow water purifiers and 3 NanoTrap filters certified by the WQA for meeting NSF/ANSI 401 standards * 40 Reverse Osmosis (RO) water purifiers recognized for microplastic removal by Intertek SEOUL, South Korea, March 28, 2024 /PRNewswire/ -- An analysis by the World Wildlife Fund (...

2024-03-28 15:00 4763

Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients

ST. GALLEN, SWITZERLAND, March 28, 2024 /PRNewswire/ -- CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adul...

2024-03-28 15:00 1646

TCI Gene Enhancing Malaysia's Preventive Healthcare In Collaboration With ALPRO Pharmacy

TAIPEI, March 28, 2024 /PRNewswire/ -- TCI Gene announced a strategic partnership with Alpro Pharmacy, a renowned chain pharmacy leader inMalaysia, to exclusively offer its genetic assessment services to Malaysians. TCI Gene and Alpro Pharmacy aims to provide Malaysians with better preventive hea...

2024-03-28 12:30 2005

XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024

BEIJING and HONG KONG, March 28, 2024 /PRNewswire/ -- XtalPi, a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, today announced it will present a poster showcasing the latest a...

2024-03-28 09:05 2101

Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023

SHANGHAI, March 28, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced its financial results for ...

2024-03-28 07:01 3608

1 ... 110 111 112113114 115 116 ... 849

Week's Top Stories

Most Reposted

QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology

[Picked up by 303 media titles]

2024-11-26 18:49

ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability

[Picked up by 296 media titles]

2024-11-28 17:24